secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2026-09-02T12:31:13+00:00
Accession:  0001193125-26-379420
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare names Clay Ritchey CEO; Kevin Coop steps down
-------------------------------------------------------------------

- Clay Ritchey named CEO and board member effective Sept 8, 2026; Kevin Coop departed Aug 31, 2026.
- Employment terms: $500k base salary, 87.5% target bonus, $4M equity grant (65% time-based, 35% performance-based).
- Ritchey previously CEO of Verato (2021-2026), Evariant, and Equinox; brings 25+ years healthcare tech experience.
- Coop's departure not due to disagreement; separation agreement to be filed later.
- Company cites upcoming AI-powered platform as growth catalyst under new CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000119312526379420/0001193125-26-379420-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000119312526379420/dh-20260828.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-379420

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer